Maternal and neonatal vaccination protects newborn baboons from pertussis infection

Journal of Infectious Diseases

Volumn 210, Issue 4, 2014, Pages 604-610

  Warfel, Jason M ^a   Papin, James F ^b   Wolf, Roman F ^b   Zimmerman, Lindsey I ^a   Merkel, Tod J ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Animal models; Baboon; Maternal vaccination; Neonatal vaccination; Pertussis

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INFANT; INFECTION PREVENTION; LEUKOCYTOSIS; LUNG EDEMA; NEWBORN; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; VACCINATION;

ANIMAL MODELS; BABOON; MATERNAL VACCINATION; NEONATAL VACCINATION; PERTUSSIS;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; FEMALE; IMMUNIZATION SCHEDULE; PAPIO; PERTUSSIS VACCINE; PREGNANCY; VACCINATION; WHOOPING COUGH;

EID: 84905586353     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu090     Document Type: Article

References (40)

1. Pertussis. In: Epidemiology and prevention of vaccine-preventable diseases. 12th ed. Atlanta: Centers for Disease Control and Prevention, 2011: 215-32.
2. Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediat Infect Dis J 2009; 28: 194-8.
3. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr 2012; 161: 1091-6.
4. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18: 326-82.
5. McIntyre P, Wood N. Pertussis in early infancy: disease burden and preventive strategies. Curr Opin Infect Dis 2009; 22: 215-23.
6. Namachivayam P, Shimizu K, Butt W. Pertussis: severe clinical presentation in pediatric intensive care and its relation to outcome. Pediatr Crit Care Med 2007; 8: 207-11.
7. Paddock CD, Sanden GN, Cherry JD, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008; 47: 328-38.
8. Smith C, Vyas H. Early infantile pertussis; increasingly prevalent and potentially fatal. Eur J Pediatr 2000; 159: 898-900.
9. Halasa NB, Barr FE, Johnson JE, Edwards KM. Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role? Pediatrics 2003; 112: 1274-8.
10. Mikelova LK, Halperin SA, Scheifele D, et al. Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr 2003; 143: 576-81.
11. Ulloa-Gutierrez R, Boza R, Carvajal-Riggioni D, Baltodano A. Pertussis: should we improve intensive care management or vaccination strategies? Exp Rev Vacines 2011; 10: 49-53.
12. Skoff TH, Cohn AC, Clark TA, Messonnier NE, Martin SW. Early Impact of the US Tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med 2012; 166: 344-9.
13. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23: 985-9.
14. Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007; 26: 238-42.
15. Wendelboe AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol 2007; 4: 15.
16. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012; 54: 78-84.
17. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis 2011; 52: 157-62.
18. Healy CM, Rench MA, Castagnini LA, Baker CJ. Pertussis immunization in a high-risk postpartum population. Vaccine 2009; 27: 5599-602.
19. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014; 111: 787-92.
20. Belloni C, De Silvestri A, Tinelli C, et al. Immunogenicity of a threecomponent acellular pertussis vaccine administered at birth. Pediatrics 2003; 111: 1042-5.
21. Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010; 29: 209-15.
22. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011; 60: 1424-6.
23. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013; 62: 131-5.
24. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanusdiphtheria- pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011; 204: 334 e1-5.
25. Leuridan E, Hens N, Peeters N, de Witte L, Van der Meeren O, Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011; 30: 608-10.
26. Van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990; 161: 487-92.
27. Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis 2012; 206: 902-6.
28. Warfel JM, Beren J, Kelly VK, Lee G, Merkel TJ. Nonhuman primate model of pertussis. Infect Immun 2012; 80: 1530-6.
29. Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol 2013; 6: 787-96.
30. Carter AM. Animal models of human placentation-a review. Placenta 2007; 28 (Suppl A): S41-7.
31. Luckett WP. Comparative development and evolution of the placenta in primates. Contrib Primatol 1974; 3: 142-234.
32. Shearer MH, Dark RD, Chodosh J, Kennedy RC. Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diagn Lab Immunol 1999; 6: 953-8.
33. Payton ME, d'Offay JM, Prado ME, et al. Comparative transmission of multiple herpesviruses and simian virus 40 in a baboon breeding colony. Comp Med 2004; 54: 695-704.
34. Wolf RF, Eberle R, White GL. Generation of a specific-pathogen-free baboon colony. J Am Assoc Lab Anim Sci 2010; 49: 814-20.
35. Warfel JM, Beren J, Kelly VK, Lee G, Merkel TJ. A non-human primate model of pertussis. Infect Immun 2012; 80: 1530-6.
36. Meade BD, Deforest A, Edwards KM, et al. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 1995; 96: 570-5.
37. Englund JA, Anderson EL, Reed GF, et al. The effect ofmaternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995; 96: 580-4.
38. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008; 153: 327-32.
39. Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008; 152: 655-60, 660 e1.
40. Libster R, Edwards KM. Re-emergence of pertussis: what are the solutions? Exp Rev of Vaccines 2012; 11: 1331-46.